Longevity News

A novel design of chimeric multi-epitope vaccine based on moonlighting proteins of Anaplasma marginale is identified by protective antibodies

Source: Nature - Biotechnology • Published: 29 Aug 2026, 00:00

A novel design of chimeric multi-epitope vaccine based on moonlighting proteins of Anaplasma marginale is identified by protective antibodies

How a computationally designed chimeric multi-epitope vaccine against a cattle tick‑borne pathogen was created and validated by antibody recognition.

Key Takeaways
  • It is citable and carries a permanent DOI
  • This version is subject to further edits and will be replaced automatically by the final Version of Record
  • Bovine anaplasmosis is a disease caused by Anaplasma marginale that affects cattle
Read Original Source

Continue exploring

Related longevity signals

Nature - BiotechnologyProteome-wide immunoinformatics and molecular dynamics reveal a multi-epitope vaccine construct targeting Nipah virus glycoprotein GA computational research article describing design and in silico evaluation of a multi-epitope vaccine targeting a viral surface glycoprotein, inviting readers curious about bioinformatics-driven vaccine development.Nature - BiotechnologyDesign and characterization of an injectable biohybrid hydrogel based on chitosan/silk fibroin/hyaluronic acid and containing bioactive glass for bone tissue engineeringCovers development and lab characterization of an injectable biohybrid hydrogel combining natural polymers and bioactive glass for bone repair applications.Fight Aging!Cytotoxic CD4+ T Cells in Aging, Both Protective and HarmfulA review examines cytotoxic CD4+ T cells that expand with age and how their protective and pathological roles influence age-related diseases.Nature - BiotechnologyComputational activation of CISD3 by a novel flavonoid compound for cardiac ageing and cardiovascular healthThis article previews a computational drug‑discovery study proposing a novel flavonoid as a candidate activator of a mitochondrial protein linked to cardiac ageing. It invites readers interested in molecular modelling, cardiometabolic interventions, and preclinical therapeutic strategies.